Menu

Month: December 2023

340B Outlook from Capitol Hill, Federal Courts, and the States

Views
Monday, January 29 from 8:45 – 9:50AM PST, Marriott Marquis San Diego Marina

SPONSORED CONTENT

Get the latest developments in the 340B program with some of the most respected experts in the field. Verity Solutions will be hosting this lively panel discussion again where you will get an up-to-the-minute report on hot button topics related to the policy, compliance, and regulatory aspects of the 340B program.

Among the topics to be covered:

· Developments on 340B contract pharmacy restrictions, state laws, and litigation

· Update from Washington, D.C., and the states on 340B legislative activity

· 340B provider reporting and transparency

· Future of 340B patient definition considering Genesis federal court ruling

Topics will be updated for any late-breaking news, and there will be opportunity

…
Read More »

Arkansas, Novo Nordisk Clash Over Court’s Role in Contract Pharmacy Law Enforcement

Views
Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
Novo Nordisk and the Arkansas Insurance Department (AID) are sparring in court over whether a federal district court should hear [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Wisconsin State Senators Introduce PBM 340B Underpayment Bill

Views
Wisconsin lawmakers have introduced bills in both legislative chambers that would bar PBMs from differentially reimbursing providers on the basis of their 340B status.
Wisconsin state senators recently introduced a bill that would prohibit pharmacy benefit managers (PBMs) from underpaying 340B covered entities. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Reforms Needed, Says Former Presidential Candidate, Drug Industry Consultant

Views
Howard Dean, a former Democratic presidential candidate who has consulted for the drug industry, said the 340B program is in need of reforms.
The 340B program has become “a multibillion-dollar boondoggle for hospital mega-chains” and needs reform, says Howard Dean, a one-time Democratic [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report